Zacks.com on MSN23 小时
NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study
InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...
Too Old to Operate2 天
Surgical and Endovascular Approaches to Extracranial Carotid Artery Aneurysms
The following is a summary of “Management of large or giant Extracranial carotid artery aneurysms: a single-center experience ...
Endovascular Today2 天
InspireMD Commences CGUARDIANS II Pivotal Study of CGuard Prime Carotid Stent System in TCAR
InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...
Why people hear pulse in their ears, know the reason here
Pulsatile tinnitus, a rhythmic sound that matches the heartbeat, is caused by turbulent blood flow in the neck or head, with ...
ScienceAlert on MSN6 天
Drinking Cocoa May Protect Your Body From Fatty Foods And Stress
In a randomized, double-blinded trial of healthy adults, researchers at the University of Birmingham have shown that drinking ...
MassDevice3 天
InspireMD begins pivotal study of CGuard Prime in TCAR procedures
InspireMD enrolled the first patient in its CGUARDIANS II pivotal study, which will evaluate the CGuard Prime Carotid Stent ...
InspireMD initiated with a Buy at Lake Street
Lake Street analyst Frank Takkinen initiated coverage of InspireMD (NSPR) with a Buy rating and $5 price target InspireMD’s CGuard carotid ...